Condition
Neoplasm, Esophageal
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Terminated1
Unknown1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT02530983Recruiting
Mayo Clinic Upper Digestive Disease Survey
NCT03108885Terminated
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
NCT03791905Phase 2UnknownPrimary
PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
Showing all 3 trials